Time to include high-risk early ovarian cancer in randomized phase III trials of advanced ovarian cancer.
Vergote
Ignace
I
Amant
Frederic
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D016019:Survival Analysis; D013997:Time Factors